| Metric | Value ($ M) | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Revenue | 74.54 | 11.8% | 0.3% |
| Total Income | 74.54 | 11.8% | 0.3% |
| Expenditure | 100.89 | 20.7% | 2.3% |
| PBT | -62.26 | 4253.9% | 48.8% |
| Net Profit | -62.63 | 3718.9% | 48.6% |
| OPM | -35.35% | 10.01pp | 3.49pp |
| NPM | -84.02% | 81.56pp | |
| EPS | -0.18 | 1700.0% | 83.8% |
Canopy Growth Reports Q3 FY2026: Net Revenue $75M, Net Loss Narrowed
04 May 2026 · 4 May, 1:22 am
Summary
Canopy Growth Corporation reported its Q3 FY2026 financial results, showing a narrowed net loss and adjusted EBITDA loss compared to the previous year. Consolidated net revenue remained flat at $75M, while cannabis net revenue increased by 4%. The company highlighted strength in Canada, particularly in medical and adult-use cannabis segments. Management is focused on sharpening execution and closing the acquisition of MTL Cannabis to further strengthen their platform.
Key Highlights
- 1
Canopy Growth's net loss in Q3 FY2026 narrowed by 49% year-over-year.
- 2
Adjusted EBITDA loss narrowed by 17% year-over-year in Q3 FY2026, driven by strong sales execution and SG&A cost savings.
- 3
Consolidated net revenue in Q3 FY2026 was $75M, remaining flat compared to Q3 FY2025.
- 4
Cannabis net revenue in Q3 FY2026 increased by 4% to $52M compared to Q3 FY2025.
- 5
Canada medical cannabis net revenue in Q3 FY2026 increased by 15% to $23M compared to Q3 FY2025.
- 6
Canada adult-use cannabis net revenue in Q3 FY2026 increased by 8% to $23M compared to Q3 FY2025.
- 7
Storz & Bickel net revenue in Q3 FY2026 decreased 9% year-over-year to $23M, but increased 45% sequentially compared to Q2 FY2026.
Management Comments
Luc Mongeau
“The third quarter of fiscal 2026 reflects improving fundamentals and a more focused, integrated operating model across the business, led by strength in Canada. As we continue sharpening execution and move toward closing the acquisition of MTL Cannabis, we see a clear opportunity to further strengthen our platform over time.”
Tom Stewart
"The decisive cost reduction actions that we have taken to date in fiscal 2026 have strengthened our current year financial performance and will ensure we are well positioned as we close out the fiscal year. With the right-sizing of our cost structure and the expected growth across our core businesses, we are confident that we can achieve our goal of delivering positive Adjusted EBITDA during fiscal 2027.”
Informational and educational content only. Not investment advice.